T1	Participants 112 160	patients with lymphoma and resolved hepatitis B.
T2	Participants 1935 1982	patients with lymphoma and resolved hepatitis B
T3	Participants 375 437	Eighty patients with CD20(+) lymphoma and resolved hepatitis B
